ArticleThe Lancet. Oncology2020
Fulvestrant plus capivasertib for metastatic breast cancer.
Ethan B Ludmir et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleThe Lancet. Oncology2020
Ethan B Ludmir et al.PubMed ↗Publisher ↗
No numbers read from the abstract.